论文部分内容阅读
本文探讨选择性血清S_2受体抑制剂Ketanserin对轻、中度原发性高血压的降压效果,Ketanserin是在不影响血压调节激素及其代谢的情况下降低血压的。治疗对象为24例轻、中度原发性高血压患者,男17例、女7例,平均年龄50±3岁(24~69岁)。所有患者在门诊测量舒张期血压两次均在95mmHg
This article explores the hypotensive effect of selective serotonin S-2 receptor inhibitor Ketanserin on mild and moderate essential hypertension. Ketanserin reduces blood pressure without affecting the blood pressure regulating hormones and their metabolism. Treatment of 24 patients with mild to moderate essential hypertension, 17 males and 7 females, mean age 50 ± 3 years (24 to 69 years). All patients measured diastolic blood pressure at the clinic twice at 95 mmHg